Brady Martz Wealth Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Brady Martz Wealth Solutions's BMY Position: Q2 2026 in Review
Brady Martz Wealth Solutions increased its Bristol-Myers Squibb (BMY) stake by 0.28% in Q2 2026, buying an estimated $574 and bringing the position to 3,572 shares worth $206K. The position accounts for 0.03% of the portfolio, ranked #220.
Brady Martz Wealth Solutions first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $262K in Q1 2025. 803 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Brady Martz Wealth Solutions held 3,572 shares of Bristol-Myers Squibb worth $206K as of Q2 2026.
- Brady Martz Wealth Solutions bought 10 Bristol-Myers Squibb shares in Q2 2026, an estimated $574.
- Bristol-Myers Squibb made up 0.03% of Brady Martz Wealth Solutions's portfolio in Q2 2026, its #220 holding.
- Brady Martz Wealth Solutions first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
- Brady Martz Wealth Solutions's Bristol-Myers Squibb position peaked at $262K in Q1 2025.
- 803 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Brady Martz Wealth Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.